Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC). | RGLS Message Board Posts


RGLS   /  Message Board  /  Read Message

 
BOARD

GROUPS
 










Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message board, top of board
Msg  491 of 759  at  3/9/2018 2:44:01 PM  by

minicomp


 In response to msg 489 by  Steve_382
view thread

Re: Anti-miR-17 therapy delays tumorigenesis in MYC-driven hepatocellular carcinoma (HCC).

This is the original reason the anti-miR-17 program was started. It was in the AZ oncology collaboration.It is interesting that it ended up making it to the clinic in kidney disease.


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 2  
   Views: 340 []
Previous Message  Next Message    Post Message    Post a Reply return to message board, top of board


Financial Market Data provided by
.
Loading...